Document is current
Any future updates will be listed below
-
Authors
Kawai, Keita
Iwamoto, Kunihiro
Miyata, Seiko
Okada, Ippei
Ando, Motoo
Fujishiro, Hiroshige
Ando, Masahiko
Noda, Akiko
Ozaki, Norio
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP17K10272)
Japan Agency for Medical Research and Development (JP20dk0307099, JP22dk0307113)
- License Information
-
More Information
Article History
Received: 18 April 2023
Accepted: 6 December 2023
First Online: 19 December 2023
Competing interests
: KI has received speakers’ honoraria from Eisai, Kyowa, Meiji Seika Pharma, MSD, Otsuka, Sumitomo Pharma, Taisho, Takeda, Towa, and Viatris. MA has received subsidies from Kyowa Kirin. NO received research support or speakers’ honoraria from, or have served as a consultant to, Sumitomo Dainippon, Eisai, Otsuka, KAITEKI, Mitsubishi Tanabe, Shionogi, Eli Lilly, Mochida, Daiichi Sankyo, Nihon Medi-Physics, Takeda, Meiji Seika Pharma, EA Pharma, Pfizer, MSD, Lundbeck Japan, Taisho Pharma, Janssen, UCB and Shionogi, Tsumura, Novartis, and Astellas.
